BEG Health Care GmbH (manufacturer responsible for manufacturing unpackaged products, primary and secondary packaging)

The drug is used for the treatment of adults with chronic arterial disease stage III and IV (according to the Fontaine classification) who are not candidates for revascularization or for whom revascularization has been unsuccessful.

Dosage form: concentrate for infusion solution

ATC: C01EA01